This inventor holds 1 USPTO granted patent. Top assignee: New York Medical College. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: The Innovative Contributions of Jaime L. Masferrer
Introduction
Jaime L. Masferrer, an accomplished inventor based in Tarrytown, NY, has made significant strides in the field of ophthalmology with his groundbreaking patent concerning glaucoma treatment. With a focus on reducing intraocular pressure, his innovative approach underscores the importance of effective solutions in healthcare.
Latest Patents
Masferrer's notable patent presents a novel long-duration treatment for glaucoma, centered around a method and composition aimed at decreasing intraocular pressure. This invention involves administering a therapeutically effective amount of 12(R)-hydroxy-eicosa-5,8,10,14-tetraenoic acid (12(R)-HETE) to patients in need. The implications of this method are profound, as it serves to treat all types of glaucoma and is also beneficial in lowering intraocular pressure in preparation for eye surgeries, particularly cataract removal.
Career Highlights
Jaime L. Masferrer is affiliated with the New York Medical College, where his research plays a pivotal role in advancing treatment options for eye diseases. His commitment to innovation in the medical field showcases his dedication to improving patient outcomes and enhancing the quality of life for those suffering from glaucoma.
Collaborations
Throughout his career, Masferrer has collaborated with esteemed colleagues such as Michal L. Schwartzman and Michael W. Dunn. These partnerships contribute to a synergistic environment that fosters creativity and drives forward-thinking research in ophthalmology.
Conclusion
In summary, Jaime L. Masferrer is a notable inventor whose contributions to glaucoma treatment highlight the significant impact of innovation in healthcare. His patent not only addresses a critical medical need but also showcases the potential for further advancements in this vital area of medicine. The collaborations and dedication exhibited by Masferrer and his colleagues continue to inspire progress and pave the way for future inventions in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile